As of 2024-12-15, the EV/EBITDA ratio of DarioHealth Corp (DRIO) is -1.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRIO's latest enterprise value is 38.26 mil USD. DRIO's TTM EBITDA according to its financial statements is -34.02 mil USD. Dividing these 2 quantities gives us the above DRIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 22.0x | 21.7x |
| Forward P/E multiples | 21.2x - 22.6x | 21.8x |
| Fair Price | (21.54) - (22.38) | (22.06) |
| Upside | -3043.1% - -3157.6% | -3114.6% |
| Date | EV/EBITDA |
| 2024-12-12 | -1.14 |
| 2024-12-11 | -1.17 |
| 2024-12-10 | -1.10 |
| 2024-12-09 | -1.07 |
| 2024-12-06 | -1.16 |
| 2024-12-05 | -1.16 |
| 2024-12-04 | -1.16 |
| 2024-12-03 | -1.14 |
| 2024-12-02 | -1.16 |
| 2024-11-29 | -1.18 |
| 2024-11-27 | -1.11 |
| 2024-11-26 | -1.07 |
| 2024-11-25 | -1.13 |
| 2024-11-22 | -1.24 |
| 2024-11-21 | -1.22 |
| 2024-11-20 | -1.17 |
| 2024-11-19 | -1.18 |
| 2024-11-18 | -1.19 |
| 2024-11-15 | -1.16 |
| 2024-11-14 | -1.20 |
| 2024-11-13 | -1.26 |
| 2024-11-12 | -1.26 |
| 2024-11-11 | -1.28 |
| 2024-11-08 | -1.31 |
| 2024-11-07 | -1.36 |
| 2024-11-06 | -1.36 |
| 2024-11-05 | -1.29 |
| 2024-11-04 | -1.31 |
| 2024-11-01 | -1.34 |
| 2024-10-31 | -1.35 |
| 2024-10-30 | -1.39 |
| 2024-10-29 | -1.34 |
| 2024-10-28 | -1.39 |
| 2024-10-25 | -1.36 |
| 2024-10-24 | -1.33 |
| 2024-10-23 | -1.32 |
| 2024-10-22 | -1.34 |
| 2024-10-21 | -1.36 |
| 2024-10-18 | -1.42 |
| 2024-10-17 | -1.39 |
| 2024-10-16 | -1.41 |
| 2024-10-15 | -1.39 |
| 2024-10-14 | -1.43 |
| 2024-10-11 | -1.41 |
| 2024-10-10 | -1.41 |
| 2024-10-09 | -1.40 |
| 2024-10-08 | -1.45 |
| 2024-10-07 | -1.46 |
| 2024-10-04 | -1.52 |
| 2024-10-03 | -1.43 |